Paper28097409
Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer.
Jones HG and 6 others. World J Surg, 2017. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer. Papers, record 28097409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28097409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| CpG Islands | Major topic |
| Proto-Oncogene Proteins B-raf | Major topic |
| Proto-Oncogene Proteins p21(ras) | Major topic |
| Aged | |
| Aged, 80 and over | |
| DNA, Neoplasm | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Mutation | |
| Phenotype |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 15956 | Cancer Research UK | United Kingdom | PubMed |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19737509 | Heterogeneity in cancer: cancer stem cells versus clonal evolution. | Cell | 2009 | https://conductscience.org/library/papers/19737509 | PubMed |
| 2 | 22513401 | Intra-tumour heterogeneity: a looking glass for cancer? | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22513401 | PubMed |
| 3 | 19931353 | Tumor heterogeneity: causes and consequences. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/19931353 | PubMed |
| 4 | 25042786 | Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. | Nat Methods | 2014 | https://conductscience.org/library/papers/25042786 | PubMed |
| 5 | 3802089 | Growth properties of artificial heterogeneous human colon tumors. | Cancer Res | 1987 | https://conductscience.org/library/papers/3802089 | PubMed |
| 6 | 17204026 | Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. | Histopathology | 2007 | https://conductscience.org/library/papers/17204026 | PubMed |
| 7 | 21483104 | Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing. | Anal Cell Pathol (Amst) | 2011 | https://conductscience.org/library/papers/21483104 | PubMed |
| 8 | 22882224 | The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer. | Histopathology | 2012 | https://conductscience.org/library/papers/22882224 | PubMed |
| 9 | 19269522 | Barrett's oesophagus. | Lancet | 2009 | https://conductscience.org/library/papers/19269522 | PubMed |
| 10 | 11433398 | Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. | Int J Cancer | 2001 | https://conductscience.org/library/papers/11433398 | PubMed |
| 11 | 22397650 | Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22397650 | PubMed |
| 12 | 21163703 | KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. | Lancet Oncol | 2011 | https://conductscience.org/library/papers/21163703 | PubMed |
| 13 | 19884549 | KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19884549 | PubMed |
| 14 | 24352906 | Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications. | Hum Mutat | 2014 | https://conductscience.org/library/papers/24352906 | PubMed |
| 15 | 2188735 | A genetic model for colorectal tumorigenesis. | Cell | 1990 | https://conductscience.org/library/papers/2188735 | PubMed |
| 16 | 22469128 | Genetic heterogeneity and cancer drug resistance. | Lancet Oncol | 2012 | https://conductscience.org/library/papers/22469128 | PubMed |
| 17 | 21160474 | Genetic variegation of clonal architecture and propagating cells in leukaemia. | Nature | 2011 | https://conductscience.org/library/papers/21160474 | PubMed |
| 18 | 21941284 | A decade of exploring the cancer epigenome - biological and translational implications. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21941284 | PubMed |
| 19 | 16369569 | The epigenetic progenitor origin of human cancer. | Nat Rev Genet | 2006 | https://conductscience.org/library/papers/16369569 | PubMed |
| 20 | 20028768 | Three DNA methylation epigenotypes in human colorectal cancer. | Clin Cancer Res | 2010 | https://conductscience.org/library/papers/20028768 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41768137 | Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/41768137 | PubMed |
| 40302146 | Search for Mutations Connected With Non-Response to Anti-EGFR Therapy in mCRC in the Morphologically Defined Regions of Primary Tumours. | Cancer Med | 2025 | https://conductscience.org/library/papers/40302146 | PubMed |
| 39539964 | Unveiling the dynamics of circulating tumor cells in colorectal cancer: from biology to clinical applications. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39539964 | PubMed |
| 36313449 | The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses. | Front Genet | 2022 | https://conductscience.org/library/papers/36313449 | PubMed |
| 36064367 | Identification of genes with high heterogeneity of expression as a predictor of different prognosis and therapeutic responses in colorectal cancer: a challenge and a strategy. | Cancer Cell Int | 2022 | https://conductscience.org/library/papers/36064367 | PubMed |
| 35454843 | Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35454843 | PubMed |
| 35194184 | Prediction of lymph node metastasis in early colorectal cancer based on histologic images by artificial intelligence. | Sci Rep | 2022 | https://conductscience.org/library/papers/35194184 | PubMed |
| 34888246 | Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand? | Front Oncol | 2021 | https://conductscience.org/library/papers/34888246 | PubMed |
| 34485122 | Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy. | Front Oncol | 2021 | https://conductscience.org/library/papers/34485122 | PubMed |
| 34346563 | Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients. | Cancer Med | 2021 | https://conductscience.org/library/papers/34346563 | PubMed |
| 34030582 | Mapping the colorectal tumor microbiota. | Gut Microbes | 2021 | https://conductscience.org/library/papers/34030582 | PubMed |
| 33322358 | Precision Medicine for the Management of Therapy Refractory Colorectal Cancer. | J Pers Med | 2020 | https://conductscience.org/library/papers/33322358 | PubMed |
| 33284993 | Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability. | Int J Cancer | 2021 | https://conductscience.org/library/papers/33284993 | PubMed |
| 32853464 | Intratumor heterogeneity: A new perspective on colorectal cancer research. | Cancer Med | 2020 | https://conductscience.org/library/papers/32853464 | PubMed |
| 31892859 | Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma. | Cancer Cell Int | 2019 | https://conductscience.org/library/papers/31892859 | PubMed |
| 31623592 | Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer. | BMC Cancer | 2019 | https://conductscience.org/library/papers/31623592 | PubMed |
| 30477151 | Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine? | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30477151 | PubMed |
| 30405408 | Impact of Global DNA Methylation in Treatment Outcome of Colorectal Cancer Patients. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30405408 | PubMed |
| 30171333 | The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing. | J Cancer Res Clin Oncol | 2018 | https://conductscience.org/library/papers/30171333 | PubMed |
| 29947019 | Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells. | Drug Deliv Transl Res | 2018 | https://conductscience.org/library/papers/29947019 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28097409
GET https://conductscience.org/api/papers/v1/28097409/references?page=2